These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 10779132

  • 1. Glycopyrrolate treatment of drooling in an adult male patient with cerebral palsy.
    Neverlien PO, Sorumshagen L, Eriksen T, Grinna T, Kvalshaugen H, Lind AB.
    Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):320-2. PubMed ID: 10779132
    [Abstract] [Full Text] [Related]

  • 2. [Glycopyrrolate treatment for drooling in an adult with cerebral palsy].
    Neverlien PO, Sørumshagen L, Eriksen T, Grinna T, Kvalshaugen H, Lind AB.
    Tidsskr Nor Laegeforen; 2001 Jan 20; 121(2):187-8. PubMed ID: 11475197
    [Abstract] [Full Text] [Related]

  • 3. Glycopyrrolate for chronic drooling in children.
    Eiland LS.
    Clin Ther; 2012 Apr 20; 34(4):735-42. PubMed ID: 22445330
    [Abstract] [Full Text] [Related]

  • 4. Glycopyrrolate treatment of chronic drooling.
    Blasco PA, Stansbury JC.
    Arch Pediatr Adolesc Med; 1996 Sep 20; 150(9):932-5. PubMed ID: 8790123
    [Abstract] [Full Text] [Related]

  • 5. Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions.
    Garnock-Jones KP.
    Paediatr Drugs; 2012 Aug 01; 14(4):263-9. PubMed ID: 22646067
    [Abstract] [Full Text] [Related]

  • 6. Glycopyrrolate for drooling in children with medical complexity under three years of age.
    Lovardi E, De Ioris MA, Lettori D, Geremia C, Staccioli S, Bella GD, Scrocca R, Scarselli A, Aversa M, De Peppo F, Campana A, Castelli E.
    Ital J Pediatr; 2022 Jan 08; 48(1):2. PubMed ID: 34998418
    [Abstract] [Full Text] [Related]

  • 7. Oral glycopyrrolate alleviates drooling in a patient with tongue cancer.
    Olsen AK, Sjøgren P.
    J Pain Symptom Manage; 1999 Oct 08; 18(4):300-2. PubMed ID: 10534970
    [Abstract] [Full Text] [Related]

  • 8. Glycopyrrolate for treatment of clozapine-induced sialorrhea in adults.
    Blissit KT, Tillery E, Latham C, Pacheco-Perez J.
    Am J Health Syst Pharm; 2014 Aug 01; 71(15):1282-7. PubMed ID: 25027535
    [Abstract] [Full Text] [Related]

  • 9. Compounded glycopyrrolate is a compelling choice for drooling children: five years of facility experience.
    Zanon D, Tumminelli C, Galimberti AMC, Torelli L, Maestro A, Barbi E, Maximova N.
    Ital J Pediatr; 2021 Nov 06; 47(1):222. PubMed ID: 34742343
    [Abstract] [Full Text] [Related]

  • 10. Glycopyrronium for severe drooling in children.
    Drug Ther Bull; 2017 Aug 06; 55(8):93-96. PubMed ID: 28808084
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study.
    Liang CS, Ho PS, Shen LJ, Lee WK, Yang FW, Chiang KT.
    Schizophr Res; 2010 Jun 06; 119(1-3):138-44. PubMed ID: 20299191
    [Abstract] [Full Text] [Related]

  • 12. The Effect of Nebulized Glycopyrrolate on Posterior Drooling in Patients with Brain Injury: Two Cases of Different Brain Lesions.
    Lee ZI, Yu KJ, Lee DH, Hong SK, Woo SB, Kim JM, Park D.
    Am J Phys Med Rehabil; 2017 Aug 06; 96(8):e155-e158. PubMed ID: 28081026
    [Abstract] [Full Text] [Related]

  • 13. The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.
    Parr JR, Weldon E, Pennington L, Steen N, Williams J, Fairhurst C, O'Hare A, Lodh R, Colver A.
    Trials; 2014 Feb 17; 15():60. PubMed ID: 24533890
    [Abstract] [Full Text] [Related]

  • 14. Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
    Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Moran M.
    Arch Pediatr Adolesc Med; 2000 Dec 17; 154(12):1214-8. PubMed ID: 11115305
    [Abstract] [Full Text] [Related]

  • 15. Management of drooling: 10 years after the Consortium on Drooling, 1990.
    Blasco PA.
    Dev Med Child Neurol; 2002 Nov 17; 44(11):778-81. PubMed ID: 12418620
    [No Abstract] [Full Text] [Related]

  • 16. Nebulized glycopyrrolate for drooling in a motor neuron patient.
    Strutt R, Fardell B, Chye R.
    J Pain Symptom Manage; 2002 Jan 17; 23(1):2-3. PubMed ID: 11779659
    [No Abstract] [Full Text] [Related]

  • 17. Preliminary study of glycopyrrolate in the management of drooling.
    Stern LM.
    J Paediatr Child Health; 1997 Feb 17; 33(1):52-4. PubMed ID: 9069045
    [Abstract] [Full Text] [Related]

  • 18. Anticholinergic medications for reducing drooling in children with developmental disability.
    Reid SM, Westbury C, Guzys AT, Reddihough DS.
    Dev Med Child Neurol; 2020 Mar 17; 62(3):346-353. PubMed ID: 31495925
    [Abstract] [Full Text] [Related]

  • 19. Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy.
    Bachrach SJ, Walter RS, Trzcinski K.
    Clin Pediatr (Phila); 1998 Aug 17; 37(8):485-90. PubMed ID: 9729704
    [Abstract] [Full Text] [Related]

  • 20. Glycopyrronium 320 μg/mL in children and adolescents with severe sialorrhoea and neurodisabilities: A randomized, double-blind, placebo-controlled trial.
    Fayoux P, Dinomais M, Shaw H, Villain F, Schwartz D, Rondeau S, Letellier G, Auvin S.
    Dev Med Child Neurol; 2024 Jul 17; 66(7):910-918. PubMed ID: 38214675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.